During telophase, the nuclear envelope (NE) reforms around daughter nuclei to ensure proper segregation of nuclear and cytoplasmic contents [1] [2] [3] [4] . NE reformation requires the coating of chromatin by membrane derived from the endoplasmic reticulum, and a subsequent annular fusion step to ensure that the formed envelope is sealed 1, 2, 4, 5 . How annular fusion is accomplished is unknown, but it is thought to involve the p97 AAA-ATPase complex and bears a topological equivalence to the membrane fusion event that occurs during the abscission phase of cytokinesis 1,6 . Here we show that the endosomal sorting complex required for transport-III (ESCRT-III) machinery localizes to sites of annular fusion in the forming NE in human cells, and is necessary for proper post-mitotic nucleocytoplasmic compartmentalization. The ESCRT-III component charged multivesicular body protein 2A (CHMP2A) is directed to the forming NE through binding to CHMP4B, and provides an activity essential for NE reformation. Localization also requires the p97 complex member ubiquitin fusion and degradation 1 (UFD1). Our results describe a novel role for the ESCRT machinery in cell division and demonstrate a conservation of the machineries involved in topologically equivalent mitotic membrane remodelling events.
During telophase, the nuclear envelope (NE) reforms around daughter nuclei to ensure proper segregation of nuclear and cytoplasmic contents [1] [2] [3] [4] . NE reformation requires the coating of chromatin by membrane derived from the endoplasmic reticulum, and a subsequent annular fusion step to ensure that the formed envelope is sealed 1, 2, 4, 5 . How annular fusion is accomplished is unknown, but it is thought to involve the p97 AAA-ATPase complex and bears a topological equivalence to the membrane fusion event that occurs during the abscission phase of cytokinesis 1, 6 . Here we show that the endosomal sorting complex required for transport-III (ESCRT-III) machinery localizes to sites of annular fusion in the forming NE in human cells, and is necessary for proper post-mitotic nucleocytoplasmic compartmentalization. The ESCRT-III component charged multivesicular body protein 2A (CHMP2A) is directed to the forming NE through binding to CHMP4B, and provides an activity essential for NE reformation. Localization also requires the p97 complex member ubiquitin fusion and degradation 1 (UFD1). Our results describe a novel role for the ESCRT machinery in cell division and demonstrate a conservation of the machineries involved in topologically equivalent mitotic membrane remodelling events.
The ESCRT-III complex performs a topologically unique membrane fusion, allowing the release of enveloped retroviruses during viral budding, intraluminal vesicles during multivesicular body biogenesis, and daughter cells during the abscission phase of cytokinesis [7] [8] [9] [10] [11] . We found that as well as localizing to the midbody during late cytokinesis, endogenous ESCRT-III components CHMP2A and CHMP2B encircled the forming daughter nuclei during telophase (Fig. 1a, b and Extended Data Fig. 1a ). CHMP2A localization was sensitive to CHMP2A-targeting short interfering RNA (siRNA; Extended Data Fig. 1b ) and was not continuous; instead we found that CHMP2A adopted a transient punctate localization around the decondensing nuclei during telophase (Extended Data Fig. 1c and Supplementary Video 1). By scoring localization in HeLa cells stably expressing mCherry-tubulin (cell cycle of 21.5 6 1.7 h (mean 6 s.d.), n 5 93), we estimate the duration of CHMP2A localization to be 96 6 8.9 s. We found cells expressing green fluorescent protein (GFP)-tagged CHMP4B (ref. 12 ) also displayed a transient, punctate, juxta-nuclear localization during telophase with recruitment of GFP-CHMP4B lasting 225 6 66 s (n 5 8) and individual puncta lasting 75 6 46 s (n 5 92; Extended Data Fig. 1d and Supplementary Video 2). Telophase ESCRT-III localization was observed in other cell lines, including human diploid fibroblasts (Extended Data Fig. 1e ). Using HeLa cells stably expressing a yellow fluorescent protein (YFP)-tagged nuclear envelope marker (lamin associated protein 2b, YFP-LAP2b) 13 , we determined that the juxtanuclear localization corresponded to the forming nuclear envelope. Here, we observed colocalization with the lamin B receptor (LBR) 14 ( Fig. 1c ) and demonstrated that CHMP2A localization occurred before appreciable formation of a nuclear lamina or nuclear pore complexes (Extended Data Fig. 1f, g) . While mitotic chromatin association of ESCRT-III has been previously reported 15 , its function remains unknown. To investigate the role of ESCRT components at the NE, we used siRNA to deplete these proteins 16 . As described previously 17 , depletion of ESCRT components produced aberrant nuclei, and these defects phenocopied those produced by depletion of proteins required for NE reformation 18 (Extended Data Fig. 1h ). NE reformation is thought to be a two-phase process, separable into membrane fusion events that create an expanding reticular network with subsequent annular fusion of holes within this network to create a sealed barrier 1 . We next used correlative light-electron microscopy (Extended Data Fig. 2a -d) to examine telophase ESCRT-III NE localization. We found that at the stage of ESCRT-III recruitment, the NE had incompletely formed ( Fig. 1d ). Two populations of CHMP2A-positive membranes were found. First, isolated CHMP2A-decorated vesicles were observed in the cytoplasm, proximal to the forming NE (5.7 6 4.2% of total cellular gold, Extended Data Fig. 2e , i). Second, CHMP2Adecorated double-membrane sheets were observed to coat the chromatin (51 6 1.7% of total cellular gold was within 100 nm of the NE). On these sheets, CHMP2A localized to discrete regions, with intact NE being devoid of label, but with CHMP2A preferentially (Extended Data Fig. 2h ) decorating nucleo-cytoplasmic channels (mean diameter 38.4 6 12.5 nm (6 s.e.m.), n 5 2 from 17 determinations) between the forming double membranes of the NE (Fig. 1d , Extended Data Figs 2d-g and 3a-d and Supplementary Videos 3 and 4). These channels must be resolved through annular fusion, and given the observed localization and topological equivalence with cytokinetic abscission (Fig. 1e ), we speculated that ESCRT-III might be involved in this process.
Requirements for CHMP2A localization to the telophase NE were revealed through depletion of partner ESCRT proteins, with CHMP4B and CHMP3, as for other ESCRT-dependent membrane remodelling events, having a major role in this recruitment ( Fig. 2a ). We used siRNA-resistant Flag-tagged CHMP2A expressed at near-endogenous levels to report localization in the presence of CHMP2A siRNA (Fig. 2b, c ). Through introduction of mutations targeting known binding partners, we found, as for midbody recruitment and cytokinetic abscission (Extended Data Fig. 4a, b ), and consistent with the previously determined telophase localization of GFP-CHMP4B (Extended Data Fig. 1d ), that while CHMP2A R -Flag localized to the forming NE, disrupting interaction with CHMP4 proteins by mutation of Arg24, Arg27 and Arg31 to Ala (CHMP2A R -Flag(RRR/AAA)) 16 abolished this localization. Mutation of the amino-terminal CHMP2A a 0 helix 19 , or residues involved in the interaction with VPS4 (ref. 16 ) had no effect on NE localization ( Fig. 2c and Extended Data Fig. 4a ). These data indicate that CHMP2A is recruited to the forming NE through classical assembly of the ESCRT-III complex.
The p97 AAA-ATPase controls both phases of NE reformation; together with its adaptor protein p47, it regulates membrane delivery and NE expansion, whereas through its adaptors nuclear protein localization 4 (NPL4) and UFD1 it regulates annular fusion 6 . Through NPL4 and UFD1, the p97 complex extracts ubiquitinated aurora-B, a chromosomal passenger complex component, from chromatin to allow chromatin decondensation and membranation 20, 21 . Given our observed ESCRT-III localization ( Fig. 1 ) and known interactions of ESCRT-III components with the chromosomal passenger complex 13 , we screened the ESCRT machinery for interaction with the p97 complex by yeast two-hybrid assay (Extended Data Fig. 5a-d ). We found that CHMP2A bound specifically to UFD1 and confirmed this interaction by direct binding and co-precipitation assays (Fig. 3a, b and Extended Data Fig. 5e-h) . We mapped the interaction with CHMP2A to the carboxy terminus of UFD1 (Extended Data Fig. 5f , g) and found that truncation of the C terminus of CHMP2A, or removal of the autoinhibitory helix (a5), prevented interaction with UFD1 ( Fig. 3a ). We used siRNA targeting UFD1 (also known as UFD1L) (Extended Data Fig. 6a ); although its partner protein, p97, was required for EGFR degradation 22 , we found cells depleted for UFD1 degraded EGFR normally (Extended Data Fig. 6b ), allowed release of HIV-1-based lentivirus (Extended Data Fig. 6c ), and completed cytokinesis normally as previously reported 21 (Extended Data Fig. 6d ). However, while cells depleted for UFD1 recruited CHMP2A to the midbody (Fig. 3d ), recruitment of CHMP2A to the forming NE was impaired ( Fig. 3c, d ).
To examine mitotic roles for ESCRT-III in NE reformation, we imaged synchronized cultures of cells stably expressing both histone-2B-mCherry (H2B-mCh) and YFP-LAP2b, and quantified the time taken to enclose the chromatin with YFP-LAP2b-positive NE. We were surprised to find that cells lacking ESCRT-III, but not UFD1, enclosed their chromatin faster than control cells (Extended Data Fig.  7a -c). To explore the integrity of the nascent NE in CHMP2Adepleted cells, we followed a protocol similar to that recently described 23 and imaged synchronized cultures of HeLa cells stably expressing both H2B-mCh and GFP-tagged b-galactosidase (bGal) fused to the nuclear localization signal (NLS) from Simian virus 40 (GFP-NLS-bGal) 24 . GFP-NLS-bGal is released from the nucleus after NE breakdown at mitotic onset, and returned after formation of transport-competent nuclear pores during NE reformation (Extended Data Fig. 8a, b ). We found that the rate of GFP-NLS-bGal return to the nucleus was slower in ESCRT-III-depleted cells Fig. 2h . e, Schematic depicting topological equivalence between annular fusion of the NE and ESCRTdependent membrane fusion events. MVB, multivesicular body. reconstructions. e, The percentage of discontinuities smaller than 65 nm was scored. Discontinuities in this range that were not nuclear pore complexes (NPCs) as a percentage of total discontinuities (including NPCs) for n number of reconstructed tomograms: control, 9.4 6 3.0, n 5 6; CHMP2A-1, 29.9 6 4.7, P 5 0.01, n 5 12; CHMP2A-2, 28.3 6 2.0, P 5 0.021, n 5 2. The increase in the percentage of non-NPC discontinuities was assessed by two-tailed Student's t-test (average diameter of non-NPC discontinuities was 38 6 22 nm (CHMP2A-1) and 58 6 19 nm (CHMP2A-2)). f, Western blotting of lysates from siRNA-treated HeLa cells stably expressing H2B-mCh, GFP-NLS-bGal and siRNA-resistant CHMP2A R -Flag with anti-CHMP2A, anti-Flag or anti-GAPDH antisera. g, Quantification of NE sealing from cells treated with siRNA as in f and imaged from 4 independent experiments (mean nucleocytoplasmic ratio given 85 min after anaphase onset 6 s.d., two-tailed Student's t-test was used to assess significance across 4 independent experiments (*); control, 8.9 6 3.1, n 5 174 ; CHMP2A siRNA, 5.4 6 2.6, n 5 171, P 5 0.0006;
RESEARCH LETTER
was compromised by treatments that prevent ESCRT-III assembly at the NE. Results were confirmed with a second reporter (GFP-NLS) (Extended Data Fig. 9c ) and we demonstrated that nuclear retention of this probe was defective in post-mitotic ESCRT-III-depleted cells (Extended Data Fig. 9d, e ). Using correlative live-cell electron tomography, we found that CHMP2A depletion resulted in the persistence of unsealed holes in the post-mitotic NE (Fig. 4d , e and Extended Data Fig. 10a, b ). Paralleling CHMP2 requirements in lentiviral release and cytokinetic abscission (Extended Data Figs 6c and 9f), depletion of CHMP2B had minimal effect on NE integrity (Extended Data Fig. 9a, b) , while co-depletion of CHMP2A and CHMP2B disrupted NE integrity to a greater extent than CHMP2A depletion alone ( Fig. 4b ). NE integrity could be rescued by stable expression of siRNA-resistant CHMP2A-Flag (CHMP2A R -Flag), but, as with CHMP2A requirements in cytokinesis (Extended Data Fig. 4b ) and
HIV-1 release 16 , not by expression of CHMP2A R -Flag(RRR/AAA) ( Fig. 4f, g) . We describe a novel localization and function of ESCRT-III in NE remodelling at sites of annular fusion, a process markedly similar to classical ESCRT-III-mediated membrane remodelling (Extended Data Fig. 10c ). Localization is governed by classical ESCRT-III assembly mechanisms and also requires UFD1. An equivalent ESCRT-III-dependent membrane remodelling at the NE may allow viruses or megaRNPs to traverse this membrane [25] [26] [27] , and in yeast, ESCRT-III has recently been shown to participate in surveillance and extraction of defective nucleoporins at the inner nuclear membrane 28 , indicating additional ESCRT-III activities on this membrane may exist throughout the cell cycle. ESCRT-III is thus involved in regulating the quality of the NE, and gene expansion within the ESCRT machinery may have resulted from an evolutionary drive to accommodate open mitoses.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
METHODS
Cell culture. HeLa and 293T cells were gifts from J. Martin-Serrano and were cultured in DMEM containing 10% FBS, penicillin (100 U ml 21 ) and streptomycin (0.1 mg ml 21 ). GP2-293 cells were obtained from Clontech and were cultured similarly. BJ fibroblasts were obtained from the ATCC and cultured in 4:1 DMEM:199 Media, supplemented with 15% FCS, penicillin (100 U ml 21 ) and streptomycin (0.1 mg ml 21 ). Stable cells lines were generated by transduction using MLV-based retroviruses as described previously 9 , and selected using Puromycin (200 ng ml 21 ), G418 (500 mg ml 21 ) or hygromycin (200 mg ml 21 ) as necessary. Cells were sorted to monoclonality by limiting dilution or FACS. HeLa cells stably expressing mCherry-tubulin 29 or GFP-CHMP4B (ref. 12) have been described previously and were gifts from J. Martin-Serrano. MycoSensor (Agilent) was used to screen for contamination. Plasmids. Plasmids encoding TSG101, EAP20 (also known as VPS25), EAP30 (SNF8), EAP45 (VPS36), CHMP1A, CHMP1B, CHMP2A, CHMP2B, CHMP3, CHMP4A, CHMP4B, CHMP4C, CHMP5, VPS4A, LIP5 (VTA1), UBPY, CEP55, TAL, LAP2B (TMPO) and ALG2 were gifts from J. Martin-Serrano and have been described previously 8, 9, 13, 30 . Coding sequences for p97 (also known as VCP), p47 (NSFL1C), NPL4 (NPLOC4), UFD1, CHMP7, VPS4B and SPARTIN (SPG20) were amplified from IMAGE clones (6502535, 3635947, 5017718, 3507963, 5551762, 6042862 and 5313378), respectively, and were cloned into mammalian expression (pCR3.1-YFP) and yeast two-hybrid plasmids (pHB18 and pGBKT7). A plasmid encoding HD-PTP was a gift from P. Woodman and was cloned similarly. siRNAresistant CHMP2A constructs were created by introducing Gln132Gln, Ala133Ala, Glu134Glu, Ile135Ile and Asp137Asp silent mutations in the CHMP2A coding sequence by PCR. 59 EcoRI and 39 NotI sites were added to facilitate cloning. Additional CHMP2A truncations, mutations and deletions were created by standard PCR procedures. UFD1 and its deletions were cloned with 59 and 39 NotI sites into relevant expression vectors. CHMP2A constructs were subcloned into pGBKT7 and UFD1 constructs were cloned into pHB18 for yeast two-hybrid analysis. For recombinant protein expression, CHMP2A was cloned into pGEX (GE Healthcare) and UFD1 constructs were cloned into pET28a (Novagen). For glutathione S-transferase (GST)-pulldown experiments, constructs were cloned into pCAGGS-GST-EcoRI-NotI-XhoI (a gift from J. Martin-Serrano). A lentiviral expression vector (pLVXP) was a gift from M. Dodding and modified to express a GFP-EcoRI-NotI-XhoI polylinker by replacing its SnaBI/XbaI fragment with a GFP-EcoRI-XhoI-NotI-STOP-XbaI fragment, obtained by PCR from pCR3.1-GFP-EcoRI-XhoI-NotI (a gift from J. Martin-Serrano). SnaBI/XhoI fragments of pHM840 (encoding GFP-NLS-bGal and obtained from T. Stamminger via Addgene) were cloned into the SnaBI/XhoI sites of pLVXP-GFP-ENX to produce pLVXP-GFP-NLS-bGal. pLVXP-GFP-NLS was obtained by amplifying GFP using primers to incorporate a C-terminal SV40 NLS. A SnaBI/NotI fragment from pH2B-mCherry-IRES-Neo3 (a gift from U. Eggert) was subcloned into SnaBI/Not sites of pLHCX-MCS (a modified version of pLHCX containing a HindIII/MluI/SalI/XhoI/NotI/HpaI/BamHI/NsiI/ClaI MCS; a gift from T. Ng) to create pLHCX-H2B-mCh. LAP2B residues 244-454 were amplified with in-frame NotI sites and cloned into the NotI site of pMSCVneo-YFP-EXN to create pMSCVneo-YFP-LAP2b. siRNA-resistant CHMP2A constructs were cloned with C-terminal Flag extensions into EcoRI and NotI sites of pCR3.1-EXN and subcloned into pNG72-ENX (gifts from J. Martin-Serrano).
For retroviral transduction, above constructs within pMSCVneoYFP-EXN, pNG72 or pLHCX-MCS retroviral packaging vectors were transfected with pVSVG into GP2-293 cells (all from Clontech). Supernatants were collected, clarified by centrifugation (200g, 5 min), filtered (0.45 mm) and used to infect target cells in the presence of 8 mg ml 21 polybrene (Millipore) at multiplicity of infection (MOI) , 1. For lentiviral transduction, 293T cells were transfected with pCMV8.91, pVSVG and with pLVXP-GFP-NLS-bGAL or pLVXP-GFP-NLS. Supernatants were collected, clarified by centrifugation (200g, 5 min), filtered (0.45 mm) and used to infect target cells in the presence of 8 mg ml 21 polybrene (Millipore) at MOI , 1. In both cases, antibiotic selection was applied after 48 h. Antibodies. Antibodies against HSP90 (H114) were from Santa Cruz Biotechnology, TSG101 (T5701) was from Sigma, GAPDH (MAB374) was from Millipore, tubulin (DM1A) was from Sigma, CHMP2A (104771-AP) was from Proteintech, CHMP2B (ab33174) was from Abcam, CHMP4B (sc82556) was from Santa Cruz, CHMP3 (sc67228) was from Santa Cruz, UFD1 (106151-AP) was from Proteintech, anti-p24 Gag (183-H12-5C) was from the NIH AIDS Research and Reference Reagent Program, EGFR (2232) was from Cell Signaling Technology, GFP (7.1/13.1) was from Roche, LBR (SAB10400151) was from Sigma, Lamin A/C (MAB3538) was from Millipore, mAb414 was from Covance, DYKDDDDK-Tag (Flag) was from Cell Signaling Technology. Alexaconjugated secondary antibodies were from Invitrogen and horseradish peroxidase (HRP)-conjugated secondary antibodies were from Millipore.
SDS-PAGE and western blotting. Cell lysates were denatured in Laemmli buffer and resolved using SDS-PAGE gels. Resolved proteins were transferred onto nitrocellulose by western blotting and were probed with the indicated antisera in 5% milk. HRP-conjugated secondary antibodies were incubated with ECL Prime enhanced chemiluminescent substrate (GE Healthcare) and visualized by exposure to autoradiography film. Transient transfection of cDNA. HeLa cells were transfected using Lipofectamine-2000 (Life Technologies) according to the manufacturer's instructions. GP2-293 and 293T cells were transfected using linear 25-kDa polyethylenimine (PEI, Polysciences, Inc.). siRNA transfections. Cells were seeded at a density of 1 3 10 5 cells per ml (HeLa, BJ) or 2.6 310 5 cells per ml (293T) and were transfected with siRNA at 100 nM, 2 h after plating using Dharmafect-1 (Dharmacon). To minimize toxicity associated with CHMP2A and UFD1 depletion, single transfections were performed for 72 h. The following targeting sequences that have already been demonstrated to achieve potent and specific suppression of the targeted CHMP were used: control, Dharmacon non-targeting control D-001810-01. Yeast two-hybrid assays. Yeast Y190 cells were co-transformed with plasmids encoding the indicated proteins fused to the VP16 activation domain (pHB18) or the Gal4 DNA-binding domain (pGBKT7). Co-transformants were selected on SD-Leu-Trp agar for 3 days at 30 uC, collected, and LacZ activity was measured using a liquid b-galactosidase assay using chlorophenolred-b-D-galactopyranoside (Roche) as a substrate. Average b-galactosidase activities presented. Lentiviral release. 293T cells were transfected with siRNA as described above, except that the second transfection contained additionally 300 ng of HIV-1 pCMVd8.91 (a gift from T. Ng), 100 ng of pLenti-SEW (a packaging vector encoding GFP, a gift from A. Ridley) and 100 ng pVSVG. After 48 h, virions were collected from 293T supernatants by filtration (0.45 mm) and centrifugation through 20% sucrose (21,000g, 120 min), lysed, resolved by SDS-PAGE and examined by western blotting. Additionally, HeLa cells were infected with 50 ml of viral supernatant and GFP-expression in these cells was measured by western blotting. Virion release was calculated by quantifying Gag virion /Gag cellular as determined densitometry using ImageJ. Co-precipitation assays. 293T cells were co-transfected equal quantities of the indicated pCAGGS-GST construct and the relevant pCR3.1-YFP construct for 48 h. Cells were collected and lysed in 1 ml of 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 1% Triton X-100, a protease inhibitor mixture (complete mini-EDTA-free, Roche). Clarified lysates were incubated with glutathione-Sepharose beads (Amersham Biosciences) for 3 h at 4 uC and washed three times with wash buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 0.1% Triton X-100). Bead-bound proteins were recovered in Laemmli sample buffer, resolved by SDS-PAGE and examined by western blotting. Production of recombinant proteins. BL21(DE3) Escherichia-coli-expressing plasmids encoding GST-tagged or His-tagged proteins were collected in bacterial lysis buffer (20 mM Hepes, pH 7.4, 500 mM NaCl, supplemented with complete mini, EDTA-free protease inhibitor (Roche) and 1 mM phenylmethylsulfonyl fluoride (PMSF); buffers for His-tagged protein purification were supplemented with 20 mM imidazole. Cells were lysed by addition of lysosyme (1 mg ml 21 , 15 min), Triton X-100 (0.25%, 15 min) and were snap-frozen in liquid nitrogen. Cells were thawed on ice, clarified through addition of DNase1 (20 mg ml 21 ) and soluble proteins were collected by centrifugation at 28,000g for 30 min. Proteins were immobilised on Glutathione Sepharose 4b or Ni-NTA-sepharose resin, washed in wash buffer (20 mM Hepes, pH 7.4, 150 mM NaCl), containing 20 mM imidazole if required. Proteins were eluted from Glutathione Sepharose 4b resin in washbuffer supplemented with 10 mM reduced glutathione (pH 8), or were eluted from Ni-NTA sepharose with a step gradient of imidazole. CHMP2A was cleaved from the GST using AcTEV protease (Life Technologies). Protein concentrations were measured using the Qubit assay system (Life Technlogies). Microscale thermophoresis. Measurements were performed using a Monolith NT.115 instrument (Nanotemper). In brief, recombinant CHMP2A was labelled with Alexa-647 using an NHS Amine-reactive labelling kit (Nanotemper), labelling was verified by infrared imaging (Licor). 360 nM Alexa-647 CHMP2A was combined with serial dilutions of GST, His-UFD1 or His-UFD1(1-257) (maximally 52.8 mM). Interactions were performed in 150 mM NaCl, 20 mM Hepes,
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0.04% Tween-20, pH 7.4. Temperature jump and thermophoresis experiments were conducted using 100% LED illumination and 40% infrared laser power and were analysed using Nanotemper's analysis suite. Binding curves could only be generated for the CHMP2A:UFD1 interaction, affinities were calculated by the software and averaged. Fixed cell imaging. Cells were imaged using Nikon Eclipse microscopes teamed with widefield (Ti-E) and confocal (A1R or Spinning Disc) imaging systems. Widefield image stacks were iteratively deconvolved using Autoquant. Images were processed in NIS Elements and exported to Photoshop for assembly. HeLa cells were fixed in methanol (for CHMP2A staining) or 4% paraformaldehyde (PFA) and subject to processing for immunofluorescence as described previously 9 . For multinucleation and midbody arrest assays, at least 300 cells per experiment were quantified. For telophase NE localization, between 10 and 20 telophase cells per experiment were scored. For fixed cell microscopical analysis, we scanned multiple coverslips and experiments before acquiring two to three representative images for presentation in figures. Live cell imaging. HeLa cells stably expressing the indicated proteins were plated in Stickyslides (Ibidi) adhered to a glass number 1 coverslip and transfected with the indicated siRNA. Cells were synchronised using a double thymidine block, and 48 h after siRNA transfection (10.5 h after release from the second thymidine block), cells were transferred to a Nikon inverted spinning disc confocal microscope with attached environmental chamber and imaged live for 4 h using a 203 dry objective and a 1.53 magnification lens. For mitotic rim formation, three coordinates per condition were selected and frames were acquired every 1 min, rim formation was scored through manual analysis of individual frames. For nuclear accumulation of GFP-NLS and GFP-NLS-bGal, frames were acquired every 1 min. The ratio of background-corrected, area-normalized, GFP-positive pixel intensities within the cytoplasm and mCh-H2B demarcated nuclei at the indicated intervals were obtained using NIS-elements. We excluded 2 out of 98 cells from CHMP2A-1 analysis, 2 out of 60 cells from UFD1-1 analysis and 2 out of 60 cells from UFD1-3 analysis as these gave anomalous N/C (nuclear/cytoplasmic) ratios .103 s.d. from the mean. For imaging of GFP-CHMP4B recruitment to the telophase NE, cells were imaged using a 1003 oil-immersion objective and confocal slices were acquired every 30 s using a spinning disc confocal microscope. For analysis of nuclear retention, siRNA-treated HeLa cells stably expressing GFP-NLS and mCh-H2B were imaged live using a Nikon A1R confocal microscope. Between 1 and 2 h after anaphase onset, cells were subject to photo-ablation of cytosolic GFP-NLS signal by point bleaching and the recovery of cytoplasmic fluorescence from the nuclear pool was quantified for 10 min after bleaching. Correlative light electron microscopy. Around 500,000 HeLa cells were seeded in a 3.5-cm Mattek gridded dish (P35G-2-14-C-GRID). The next morning, cells were fixed in phosphate buffer containing 1% PFA for 3 min. Cells were permeabilized with 0.1% saponin in PHEM (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl 2 , pH 6.9) and processed for immunofluorescence using anti-CHMP2A primary and goat anti-rabbit Alexa-594-conjugated fluoronano-gold (Nanoprobes) and DAPI. Cells were subjected to a subsequent 10-min 3% PFA fixation and quenching before imaging on a Leica SP5 or SP8 confocal microscope.
After fluorescent imaging, cells were postfixed in glutaraldehyde, subjected to silver enhancement (Aurion RGENT SE-EM), stained with OsO 4 and uranyl acetate, dehydrated through ethanol and embedded in Epon. Blocks were trimmed to the region identified by confocal imaging and 300-nm serial sections were cut using a diamond knife 32 . For retracing of the cells of interest, sections were imaged on a FEI Tecnai12 and subsequently double tilt series of regions of interest were acquired on a FEI Tecnai20. Tilt series were reconstructed using iMOD and selected frames and movies were extracted using ImageJ.
For quantification of holes remaining in the NE after CHMP2A depletion, tomograms were acquired by CLEM as described above. Discontinuities in the NE were scored as being NPC or non-NPC on the basis of cross-sectional morphology. Internal diameters of these discontinuities were measured from reconstructed tomograms using FIJI. Discontinuities were segregated by size and whether they were identifiable as NPCs or not. A threshold was set at 65 nm (.2 s.d. smaller than the measured control NPC diameter) and the percentage of discontinuities smaller than this was displayed. At least 50 discontinuities were analysed per treatment across multiple cells from the indicated number of tomograms. Statistical analysis. Variance was analysed using an F-test, and type-relevant twotailed Student's t-tests were used to assess significance between test samples and controls. No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. ImageStream analysis. siRNA-treated HeLa cells in 6-well dishes were detached, fixed in 4% PFA, permeabilized with 0.1% Triton X-100 and stained in suspension with mAb414, Alexa-594-conjugated secondary antibodies and DAPI (at 0.1 mg ml 21 ). In-focus, single-cellular populations were acquired and a mask was applied to the DAPI channel and duplicated then dilated by three pixels to encompass the mAb414 signal surrounding the nuclei. The difference in the mAb414 signal captured by these masks was given as the nuclear envelope mAb414 and presented as a histogram. Representative images of average mAb414 intensity were extracted for presentation. Fig. 1d ; a single example of a nucleo-cytoplasmic channel was selected for 3D rendering. e-g, Z-slices extracted from tomographic reconstructions of forming NE depicting CHMP2A localization to isolated vesicles (e, i) and nucleo-cytoplasmic channels (arrows in e, ii, f, g) at the indicated Z-heights Localization of CHMP2A to nucleo-cytoplasmic channels was observed in three independent cells; data from a second cell are presented in Extended Data Fig. 3 . Note CHMP2A localization to nucleo-cytoplasmic channels is distinct from nuclear pores (asterisk in f). h, Quantification of CHMP2A labelling from two independently prepared cells. Channels were defined as discontinuities up to 80 nm, and gaps were defined as discontinuities over 80 nm. Distances of the gold-particles from channels or gaps were measured on the tomograms in three-dimensions and plotted as a histogram. Most (74.4%) of the gold label was found within 150 nm of nucleo-cytoplasmic channels, and most (70.6%) of the gold label was found more than 150 nm from the larger gaps in the NE. Scale bars, 10 mm (b) and 200 nm (f, g). 
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Extended Data Figure 6 | UFD1 depletion does not affect ESCRTdependent receptor degradation, lentivirus release or cytokinetic abscission. a, Resolved cell lysates of HeLa cells transfected with the indicated siRNA were examined by western blotting with anti-UFD1 or anti-HSP90 antisera. b, Resolved lysates of human diploid fibroblasts transfected with the indicted siRNA and treated for the indicated times with epidermal growth factor (20 ng ml 21 ) were examined by western blotting with anti-EGFR, anti-UFD1 and anti-GAPDH antisera. EGFR degradation was quantified by densitometry (n 5 3). c, Resolved cell lysates from 293T cells transfected with the indicated HIV-1 based lentiviral plasmids, a virally packaged GFP-plasmid, and the indicated siRNA were examined by western blotting with anti-p24 capsid, -HSP90, -TSG101, -CHMP2A, -CHMP2B and -UFD1 antibodies. Viral supernatants were collected and used to infect target HeLa cells. Resolved virions present in the 293T supernatant were examined by western blotting with anti-p24 capsid. Resolved lysates of infected HeLa cells were examined by western blotting with anti-GFP. Virion release was the ratio of released to cellular p24 capsid, as quantified by densitometry (n 5 2); infectivity was quantified as GFP signal in target cells, as quantified by densitometry (n 5 2). d, siRNA-transfected HeLa cells were fixed and stained with anti-tubulin. Multinucleate cells (n 5 5) or cells connected by midbodies (n 5 5) were scored visually, 300 cells scored per experiment. Data are mean 6 s.d. 
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Extended Data Figure 9 | Requirements for nucleo-cytoplasmic compartmentalization. a, Quantification of NE sealing from siRNA-treated cells as in Fig. 4b (control, 140 cells from 7 independent experiments; UFD1-1, 60 cells from 3 independent experiments, P 5 0.044; UFD1-3, 60 cells from 3 independent experiments, P 5 0.021; CHMP2B 40 cells from 2 independent experiments; two-tailed Student's t-test was used to assess significance at the 85-min time point). b, Resolved cell lysates from a were analysed by western blotting with the indicated antisera. c, NE integrity assay as performed with cells stably expressing mCh-H2B and GFP-NLS and transfected with the indicated siRNA. Differences in nucleo-cytoplasmic partitioning was assessed after plateau at the 65-min time point using a two-tailed Student's t-test (control, 79 cells from 4 independent experiments, CHMP2A-1, 60 cells from 3 independent experiments, P 5 0.048; CHMP2A-2, 52 cells from 3 independent experiments, P 5 0.011; CHMP3, 28 cells from 3 independent experiments, P 5 0.028). d, e, HeLa cells stably expressing mCh-H2B and GFP-NLS were transfected with the indicated siRNA and imaged live. 60 min after anaphase onset, cytoplasmic signal was photo-ablated (T 5 0) and recovery of cytoplasmic signal from the nuclear pool was calculated for the indicated conditions (cytoplasmic:nuclear ratio of GFP-NLS was normalized to T 5 0; control, 21 cells from 4 independent experiments; CHMP2A-1, 24 cells from 4 independent experiments, P 5 0.04; CHMP2A-2, 23 cells from 4 independent experiments, P 5 0.05; CHMP3, 15 cells from 3 independent experiments, P 5 0.004, two-tailed Student's t-test was used to assess significance after 10 min). Scale bars, 10 mm. f, Scoring of multinucleate and midbody-connected HeLa cells transfected with the indicated siRNA and stained with anti-tubulin and DAPI (300 cells analysed Fig. 4d . b, CHMP2A-depleted cells exhibited more non-NPC discontinuities per unit area, while the number of NPC per unit area was constant. Tomograms as described in Fig. 4d , e were scored for discontinuities. The internal diameter of NPCs was slightly reduced in CHMP2A-depleted cells (control, 84 6 7.6 nm, CHMP2A-1, 74 6 8.8 nm; CHMP2A-2, 74 6 5.7 nm). c, Schematic depicting topological equivalent of ESCRT-III-dependent membrane fusion events.
